Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Syros Pharmaceuticals
Syros Pharmaceuticals
Pfizer to end license deal with Syros for blood disorder therapies
Pfizer to end license deal with Syros for blood disorder therapies
Reuters
Pfizer
Syros Pharmaceuticals
sickle cell disease
beta thalassemia
Flag link:
Two cancer biotechs merge, raise cash as sector-wide downturn continues
Two cancer biotechs merge, raise cash as sector-wide downturn continues
BioPharma Dive
Syros Pharmaceuticals
Tyme Technologies
M&A
cancer
oncology
Flag link:
ESMO: Syros targets KRAS-mutant cancer as CDK7 inhibitor shows early promise
ESMO: Syros targets KRAS-mutant cancer as CDK7 inhibitor shows early promise
Fierce Biotech
ESMO
Syros Pharmaceuticals
breast cancer
Pfizer
Ibrance
Flag link:
ESMO 2021 – the jury remains out on CDK7 inhibition
ESMO 2021 – the jury remains out on CDK7 inhibition
EP Vantage
ESMO
Syros Pharmaceuticals
Carrick Therapeutics
breast cancer
Flag link:
Why So Many Biotechs Are Scrambling to Develop a Drug for the Same Rare Disease
Why So Many Biotechs Are Scrambling to Develop a Drug for the Same Rare Disease
Motley Fool
beta thalassemia
rare disease
drug development
Acceleron
Bristol-Myers Squibb
Bluebird Bio
Sangamo Therapeutics
Vertex Pharmaceuticals
Editas Medicine
Syros Pharmaceuticals
Flag link:
Here's Why Syros Pharmaceuticals Is Collapsing Today
Here's Why Syros Pharmaceuticals Is Collapsing Today
Motley Fool
Syros Pharmaceuticals
Flag link:
JPM18: Incyte and Syros to collaborate in cancer R&D
JPM18: Incyte and Syros to collaborate in cancer R&D
Biopharma Dive
Incyte
Syros Pharmaceuticals
cancer
R&D
JPMHC 2018
Flag link:
Despite sluggish IPO market, biotechs continue to lead the way
Despite sluggish IPO market, biotechs continue to lead the way
BioPharma Dive
IPOs
biotech
Reata Pharmaceuticals
Syros Pharmaceuticals
Flag link:
The 2015 Fierce 15 biotech execs take a bow
The 2015 Fierce 15 biotech execs take a bow
Fierce Biotech
Alector
Arvinas
CRISPR Therapeutics
Intellia Therapeutics
NGM Biopharmaceuticals
Padlock Therapeutics
SQZ Biotech
Revolution Medicines
Syros Pharmaceuticals
Unum Therapeutics
Yumanity Therapeutics
Flag link:
FierceBiotech's 2015 Fierce 15
FierceBiotech's 2015 Fierce 15
Fierce Biotech
Alector
Arvinas
Cell Medica
CRISPR Therapeutics
Denali Therapeutics
Intellia Therapeutics
MyoKardia
NGM Biopharmaceuticals
Padlock Therapeutics
Revolution Medicines SQZ Biotech
Surface Oncology
Syros Pharmaceuticals
Unum Therapeutics
Yumanity Therapeutics
Flag link: